Opinion statement Despite the increase of breast cancer incidence with age, approximately
7 to 10% ofwomen diagnosed with breast cancer are younger than the age 40. This …

Landmark studies have established trastuzumab in the treatment of HER2-positive breast
cancer. The present systematic review and meta-analysis aims to synthesize all available …

Over the past four decades, there has been a rising trend of delaying childbearing [1]. Given
that cancer incidence increases with age, more women are either diagnosed with cancer …

Pregnancy-associated cancer constitutes an uncommon and difficult to manage clinical
situation. It is defined as the cancer diagnosed from the first day of childbearing to 1 year …

Background Although breast cancer during pregnancy (BCDP) is rare (occurring with only
0.4% of all BC diagnoses in female patients aged 16–49 years), management decisions are …

Background Fertility and pregnancy-related issues are major concerns for young breast
cancer patients. Limited data are available on physicians' knowledge, attitudes and practice …

Because more women are waiting to have children until later in life, cancer diagnoses in
pregnancy are becoming more common. Gestational cancer is defined as a new cancer …

Pregnancy-associated breast cancer (PABC) is commonly defined as a breast cancer
occurring during pregnancy, throughout 1 year postpartum, or during lactation. Despite …

Introduction The addition of taxanes to anthracycline-based chemotherapy is considered
standard of care in the treatment of breast cancer. However, there are insufficient data …

The diagnosis of breast cancer (BC) during pregnancy is uncommon. It has varied among
different studies from 1: 10,000 to 1: 3000 of all pregnancies, with a median age of 33 years …